Horizon Discovery Group Plc (HZD):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Horizon Discovery Group Plc (HZD) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7837)・商品コード:DATA904C7837
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:37
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers services such as CRISPR screening, combination screening, in vivo assay services and cell-based assays, among others. Horizon Discovery offers its products and services to genomic research organizations, pharmaceutical, biotechnology and diagnostic companies and academic research centers for the formulation of customized medicines. The company has operations in the UK and the US. Horizon Discovery is headquartered in Cambridge, the UK.

Horizon Discovery Group Plc (HZD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Horizon Discovery Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Horizon Discovery Group Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 11
Private Equity 12
ValueAct Capital Acquires Additional Stake in Horizon Discovery Group from Woodford Investment Management 12
Partnerships 13
Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13
Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14
Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15
Horizon Discovery Enters Into Licensing Agreement With ATCC 16
Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17
Horizon Discovery Enters into Partnership 18
Sophia Genetics Enters into Agreement with Horizon Discovery Group 19
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 20
Agena Bioscience Enters into Agreement with Horizon Discovery 21
CareDx Enters into Co-Development Agreement with Horizon Discovery 22
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 23
Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 24
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25
Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 26
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27
Horizon Discovery Enters into Licensing Agreement with US Immuno-Oncology Company 28
Equity Offering 29
Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29
Horizon Discovery Group Plc – Key Competitors 30
Horizon Discovery Group Plc – Key Employees 31
Horizon Discovery Group Plc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Product News 34
Sep 25, 2017: Horizon Discovery introduces OncoSpan, the world’s largest DNA multiplex Reference Standard for oncology 34
Feb 20, 2017: Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma 35
Other Significant Developments 36
Mar 14, 2017: Horizon Discovery Enters into Agreement with a Leading Global Molecular Diagnostics Provider for Reference Standards for Non-Invasive Prenatal Testing 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Horizon Discovery Group Plc, Medical Equipment, Key Facts, 2017 2
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Horizon Discovery Group Plc, Deals By Market, 2012 to YTD 2018 8
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 11
ValueAct Capital Acquires Additional Stake in Horizon Discovery Group from Woodford Investment Management 12
Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13
Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14
Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15
Horizon Discovery Enters Into Licensing Agreement With ATCC 16
Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17
Horizon Discovery Enters into Partnership 18
Sophia Genetics Enters into Agreement with Horizon Discovery Group 19
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 20
Agena Bioscience Enters into Agreement with Horizon Discovery 21
CareDx Enters into Co-Development Agreement with Horizon Discovery 22
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 23
Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 24
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25
Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 26
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27
Horizon Discovery Enters into Licensing Agreement with US Immuno-Oncology Company 28
Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29
Horizon Discovery Group Plc, Key Competitors 30
Horizon Discovery Group Plc, Key Employees 31
Horizon Discovery Group Plc, Other Locations 32
Horizon Discovery Group Plc, Subsidiaries 32
Horizon Discovery Group Plc, Joint Venture 33

List of Figures
Horizon Discovery Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Horizon Discovery Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Horizon Discovery Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[Horizon Discovery Group Plc (HZD):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7837)販売に関する免責事項を必ずご確認ください。
★調査レポート[Horizon Discovery Group Plc (HZD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆